Suppr
超能文献

Diabetes: Doctors are told not to start new patients on GLP-1 agonists because of shortages.

作者信息

Iacobucci Gareth

机构信息

The BMJ.

出版信息

BMJ. 2023 Sep 1;382:2019. doi: 10.1136/bmj.p2019.

DOI:10.1136/bmj.p2019

PMID:37657814

Abstract

摘要

相似文献

Diabetes: Doctors are told not to start new patients on GLP-1 agonists because of shortages.

BMJ. 2023 Sep 1;382:2019. doi: 10.1136/bmj.p2019.

Recent Advances in GLP-1 Receptor Agonists for Use in Diabetes Mellitus.

Drug Dev Res. 2017 Sep;78(6):292-299. doi: 10.1002/ddr.21404. Epub 2017 Aug 8.

Management of Diabetes Mellitus in Normal Renal Function, Renal Dysfunction and Renal Transplant Recipients, Focusing on Glucagon-Like Peptide-1 Agonist: A Review Based upon Current Evidence.

Int J Mol Sci. 2019 Jun 28;20(13):3152. doi: 10.3390/ijms20133152.

Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus.

Int J Biochem Cell Biol. 2006;38(5-6):845-59. doi: 10.1016/j.biocel.2005.07.011. Epub 2005 Sep 15.

The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide.

Curr Med Res Opin. 2016;32(1):61-76. doi: 10.1185/03007995.2015.1103214. Epub 2015 Nov 11.

Can GLP-1 preparations be used in children and adolescents with diabetes mellitus?

Pediatr Endocrinol Rev. 2014 Mar;11(3):324-7.

A GLP-1/glucagon (GCG)/CCK receptors tri-agonist provides new therapy for obesity and diabetes.

Br J Pharmacol. 2022 Sep;179(17):4360-4377. doi: 10.1111/bph.15860. Epub 2022 May 20.

Awareness Of Use Of GLP-1 Agonists In The Treatment Of Diabetes Mellitus In Pakistan.

J Pak Med Assoc. 2023 Aug;73(8):1769. doi: 10.47391/JPMA.8210.

Once-weekly GLP-1R agonists: moving the goal posts.

Lancet Diabetes Endocrinol. 2018 Apr;6(4):260-261. doi: 10.1016/S2213-8587(18)30049-4. Epub 2018 Feb 1.

Effect of glucagon-like peptide 1(7-36)amide in insulin-treated patients with diabetes mellitus secondary to chronic pancreatitis.

Pancreas. 2000 Jan;20(1):25-31. doi: 10.1097/00006676-200001000-00004.

引用本文的文献

Changes in Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Exposures Following Recent Demand for Weight Management: A Retrospective Review of California Poison Control System Data.

J Pharm Technol. 2025 May 12:87551225251332212. doi: 10.1177/87551225251332212.

Impact of real-time glucose monitoring using FreeStyle Libre 3 on glycaemia in type 2 diabetes managed with basal insulin plus SGLT2 inhibitor and/or GLP-1 agonist: the FreeDM2 randomised controlled trial protocol.

BMJ Open. 2025 Apr 15;15(4):e090154. doi: 10.1136/bmjopen-2024-090154.

Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study.

Diabetes Ther. 2024 Jul;15(7):1639-1646. doi: 10.1007/s13300-024-01590-x. Epub 2024 May 9.

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update.

Endocrinol Metab (Seoul). 2024 Feb;39(1):12-22. doi: 10.3803/EnM.2024.1942. Epub 2024 Feb 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Diabetes: Doctors are told not to start new patients on GLP-1 agonists because of shortages.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译